Published On:July 11, 2017, 9:51 am
3D bioprinting is the procedure of creating spatially-controlled cell patterns in 3D printing. In which, cell function and feasibility are conserved within the printed conception. 3D Bioprinting also referred as additive manufacturing is used to create three-dimensional solid substances from a digital file which is accomplished by using linear processes. Usually, 3D bioprinting employs the layer-by-layer method to sediment materials identified as Bioinks (a blend of living cells) to produce tissue-like structures that are later used in tissue engineering and medical fields.
3D Bioprinting technology arises from modeling and prototyping in several applications for the progress of actual usable products and parts. 3D bioprinting market eases the opportunities for hips implant, prosthesis, hearing aids, contact lenses, custom-made knee, dental implants and etc. that are designed and customized according to the individual person, one of the upgrades of 3D printing is known as bio-printing or the aptitude to print living tissues. Currently, 3D bioprinting is being used to print organs and tissues which aid in research of drugs, pills, and treatments. Some of the trending technologies used in 3D bioprinting are laser-based printing, inkjet-based printing, syringe-based printing and magnetic levitation.
In 2016, the Global 3D Bioprinting Sales Market was valued approximately USD 411.4 million. It is anticipated to reach at USD 1.33 billion by 2022. The compound annual growth rate is expected to be 26.5% during the forecast period of 2017 to 2022. The global 3D bioprinting sales market has testified considerable growth in the recent years. The mounting demand for tissues and organs that are suitable for transplantation process has propelled the use of 3D bioprinting in regenerative medicine field. Rising incidence of chronic illnesses, increase in lifespan of individuals, growing demand for organ and tissue for transplants, integration of IT within the healthcare field, inadequate number of organ donors, prompt progression in 3D printing technology, and rising geriatric population; these factors are fueling the global market. In addition, significant upgrading in research and development attempts in the industry has encouraged the 3D bioprinting market. The prediction of bioprinted tissue, implants, and organs reconstructions appears affirmative in the coming future owing to the efforts of research organizations, institutes, and universities.
The major market players for the global 3D bioprinting sales market are Advanced BioMatrix, Organovo Holdings, Inc., Regenovo Biotechnology Co., Ltd., Bespoke Innovations, EnvisionTEC GmbH, 3Dynamic Systems Ltd., Nano3D Biosciences, Inc., Stratasys, Cyfuse Biomedical K.K., Aspect Biosystems Ltd., regenHU Ltd, Poietis, BioBots, Cellink, GeSiM and Exone. On the basis of product, the market industry is classified into; Laser-assisted Bioprinting, Magnetic 3D Bioprinting, Microextrusion 3D Bioprinting and Inkjet 3D Bioprinting. By application, the global market is split into; Research Applications, Clinical Applications, Regenerative Medicine, Drug and Medical Research and 3D Cell Culture. Geographically, the global market industry is segmented into regions which are Asia-Pacific, Europe, Southeast Asia, North America and rest of the world.
Request For Sample Of 3D Bioprinting Market Research Report @ https://www.qyresearchgroups.com/request-sample/425068
We will be happy to help you find what you need. Please write to us: